BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1087 related articles for article (PubMed ID: 17890317)

  • 1. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.
    Fabbri M; Garzon R; Cimmino A; Liu Z; Zanesi N; Callegari E; Liu S; Alder H; Costinean S; Fernandez-Cymering C; Volinia S; Guler G; Morrison CD; Chan KK; Marcucci G; Calin GA; Huebner K; Croce CM
    Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15805-10. PubMed ID: 17890317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A regulatory circuitry comprising TP53,
    Chen B; Wang J; Wang J; Wang H; Gu X; Tang L; Feng X
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
    Tan M; Wu J; Cai Y
    Biochem Biophys Res Commun; 2013 Sep; 438(4):673-9. PubMed ID: 23939044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.
    Huang J; Wang Y; Guo Y; Sun S
    Hepatology; 2010 Jul; 52(1):60-70. PubMed ID: 20578129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.
    Garzon R; Liu S; Fabbri M; Liu Z; Heaphy CE; Callegari E; Schwind S; Pang J; Yu J; Muthusamy N; Havelange V; Volinia S; Blum W; Rush LJ; Perrotti D; Andreeff M; Bloomfield CD; Byrd JC; Chan K; Wu LC; Croce CM; Marcucci G
    Blood; 2009 Jun; 113(25):6411-8. PubMed ID: 19211935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2 overexpression deregulates the transcriptional control of RB/E2F leading to DNA methyltransferase 3A overexpression in lung cancer.
    Tang YA; Lin RK; Tsai YT; Hsu HS; Yang YC; Chen CY; Wang YC
    Clin Cancer Res; 2012 Aug; 18(16):4325-33. PubMed ID: 22733537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A.
    Wei X; Xiang T; Ren G; Tan C; Liu R; Xu X; Wu Z
    Cell Signal; 2013 Feb; 25(2):439-46. PubMed ID: 23124077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer.
    Chen Y; Min L; Zhang X; Hu S; Wang B; Liu W; Wang R; Gu X; Shen W; Lv H; Zou J; Chen Y; Xu X; Chen L
    Oncol Rep; 2013 Oct; 30(4):1832-40. PubMed ID: 23843100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.
    Virmani A; Rathi A; Sugio K; Sathyanarayana UG; Toyooka S; Kischel FC; Tonk V; Padar A; Takahashi T; Roth JA; Euhus DM; Minna JD; Gazdar AF
    Int J Cancer; 2003 Aug; 106(2):198-204. PubMed ID: 12800194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism involved in the loss of PTEN expression in NSCLC tumor cells.
    Li G; Zhao J; Peng X; Liang J; Deng X; Chen Y
    Biochem Biophys Res Commun; 2012 Feb; 418(3):547-52. PubMed ID: 22290228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer.
    Watanabe K; Emoto N; Hamano E; Sunohara M; Kawakami M; Kage H; Kitano K; Nakajima J; Goto A; Fukayama M; Nagase T; Yatomi Y; Ohishi N; Takai D
    Int J Cancer; 2012 Jun; 130(11):2580-90. PubMed ID: 21702040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Delta DNMT3B variants and its association with promoter methylation of p16 and RASSF1A in primary non-small cell lung cancer.
    Wang J; Walsh G; Liu DD; Lee JJ; Mao L
    Cancer Res; 2006 Sep; 66(17):8361-6. PubMed ID: 16951144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer.
    Tsai KW; Wu CW; Hu LY; Li SC; Liao YL; Lai CH; Kao HW; Fang WL; Huang KH; Chan WC; Lin WC
    Int J Cancer; 2011 Dec; 129(11):2600-10. PubMed ID: 21960261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer.
    Kang N; Choi SY; Kim YK; Yoo IeR; Han DH; Lee DS; Kim YS; Hong SH; Kang JH; Lee KY; Park JK; Sung SW; Park MS; Yim HW; Kim SJ; Park JY
    Lung Cancer; 2015 Aug; 89(2):99-103. PubMed ID: 26101014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of miR-101 suppresses lung tumorigenesis through inhibition of DNMT3a-dependent DNA methylation.
    Yan F; Shen N; Pang J; Xie D; Deng B; Molina JR; Yang P; Liu S
    Cell Death Dis; 2014 Sep; 5(9):e1413. PubMed ID: 25210796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methylation of some miRNA genes is involved in the regulation of their target genes RAR-beta2 and NKIRAS1 expression in lung cancer].
    Khodyrev DS; Pronina IV; Rykov SV; Beresneva EV; Fridman MV; Kazubskaia TP; Loginov VI; Braga ÉA
    Mol Biol (Mosk); 2012; 46(5):773-85. PubMed ID: 23156677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-29s inhibit the malignant behavior of U87MG glioblastoma cell line by targeting DNMT3A and 3B.
    Xu H; Sun J; Shi C; Sun C; Yu L; Wen Y; Zhao S; Liu J; Xu J; Li H; An T; Zhou X; Ren L; Wang Q; Yu S
    Neurosci Lett; 2015 Mar; 590():40-6. PubMed ID: 25625222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.
    Vallböhmer D; Brabender J; Yang D; Schneider PM; Metzger R; Danenberg KD; Hölscher AH; Danenberg PV
    Clin Lung Cancer; 2006 Jul; 8(1):39-44. PubMed ID: 16870044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis.
    Robaina MC; Mazzoccoli L; Arruda VO; Reis FR; Apa AG; de Rezende LM; Klumb CE
    Exp Mol Pathol; 2015 Apr; 98(2):200-7. PubMed ID: 25746661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Double-Negative Feedback Interaction between MicroRNA-29b and DNMT3A/3B Contributes to Ovarian Cancer Progression.
    Teng Y; Zuo X; Hou M; Zhang Y; Li C; Luo W; Li X
    Cell Physiol Biochem; 2016; 39(6):2341-2352. PubMed ID: 27832631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.